75 completed, 51 unknown, 15 terminated, 11 withdrawn. 166 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 166 | Completed 75, Unknown 51, Terminated 15, Withdrawn 11, Recruiting 9, Not yet recruiting 3, Active not recruiting 2 |
Follow Angina Pectoris: new trials by email Literature Review of Angina Pectoris trials Research Report on Angina Pectoris
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Coronary MicrovAscular Diseases Intervention With Compound Danshen Dropping Pills Compound Danshen Dripping Pills, Placebo - Coronary Microvascular Disease | Phase 4 | Not yet recruiting | Qilu Hospital of Shandong University | 496 | 2026-10-01 | 2026-10-21 |
| Early Triple Lipid-Lowering Therapy With Bempedoic Acid After Acute Coronary Syndrome bempedoic acid, Ezetimibe, High-Intensity Statin Therapy - Acute Coronary Syndromes, Dyslipidemia | Phase 4 | Recruiting | Taipei Medical University Hospital | 400 | 2026-08-26 | 2026-09-17 |
| Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome Early P2Y12 Inhibitor Monotherapy, Standard Dual Antiplatelet Therapy - Acute Coronary Syndromes, STEMI | Phase 4 | Recruiting | Gyeongsang National University Hospital | 2200 | 2026-07-01 | 2026-11-05 |
| 1 or 6 Months of Dual Antiplatelet Therapy After Drug-coated Balloon Angioplasty for De-novo Small Coronary Artery Disease 1-Month DAPT followed by SAPT, 6-Month DAPT followed by SAPT - Stable Angina Pectoris, Coronary Artery Disease | Phase 4 | Not yet recruiting | Daejeon St. Mary's hospital | 1484 | 2026-05-01 | 2026-05-18 |
| Effect of Beta-blockers on Coronary Flow and Resistance in Patients With ANOCA Saline (NaCl), Metoprolol Tartrate - Coronary Arterial Disease (CAD), Angina (Stable) | Phase 4 | Recruiting | VZW Cardiovascular Research Center Aalst | 46 | 2025-07-03 | 2025-07-14 |
| Clinical Evaluation of Aromatic Wentong in the Treatment of Coronary Microvascular Disease Kuangxiong Aerosol, Placebo Drug - Coronary Microvascular Disease | Phase 4 | Not yet recruiting | China-Japan Friendship Hospital | 528 | 2025-04-01 | 2025-04-11 |
| The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease Tirzepatide, Placebo - Coronary Artery Disease, Coronary Microvascular Dysfunction | Phase 4 | Recruiting | Tina Vilsbøll | 124 | 2024-10-01 | 2025-05-22 |
| The Effect of Sublingual Nitroglycerin on Absolute Coronary Blood Flow Glycerin trinitrate (GTN), Saline (NaCl 0,9 %) (placebo) - Coronary Arterial Disease (CAD), Angina (Stable) | Phase 4 | Completed | VZW Cardiovascular Research Center Aalst | 40 | 2024-07-01 | 2025-03-28 |
| Qishenyiqi Dripping Pill for Coronary Microvascular Disease Qishenyiqi dripping pills 1 bag, three times a day, Placebo 1 bag, three times a day - Coronary Microvascular Disease | Phase 4 | Recruiting | Qilu Hospital of Shandong University | 162 | 2023-11-08 | 2024-11-21 |
| LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions Clinician Discretion, Beta blocker, Calcium channel blocker - Angina, Stable Ischemic Heart Disease | Phase 4 | Recruiting | Yale University | 741 | 2023-05-10 | 2026-04-07 |
| Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting De-escalated Dual Antiplatelet Therapy, Dual Antiplatelet Therapy - Coronary Artery Disease, Coronary Artery Bypass Grafting | Phase 4 | Completed | China National Center for Cardiovascular Diseases | 2300 | 2023-02-14 | 2025-08-27 |
| MIRAGE Study: Clinical Outcomes of the Mamba Sirolimus-Eluting PTCA Balloon Mamba Sirolimus-Eluting PTCA Balloon, Percutaneous Coronary Angioplasty with Sirolimus-Coated Balloon - Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)) | Phase 4 | Completed | Frisch Medical Device Private Limited | 360 | 2023-01-11 | 2026-03-11 |
| Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization Aspirin, No aspirin - Stable Angina Pectoris, Coronary Artery Disease | Phase 4 | Recruiting | Takeshi Morimoto | 2890 | 2022-06-14 | 2025-03-11 |
| Study of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoing Individually Optimized Lipid-lowering Therapy, in Participants With Hypercholesterolemia Inclisiran Sodium, Placebo - Hypercholesterolemia | Phase 4 | Completed | Novartis Pharmaceuticals | 1770 | 2022-04-08 | 2026-04-14 |
| Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease Bisoprolol, Diltiazem, Placebo - Coronary Microvascular Dysfunction, Microvascular Angina | Phase 4 | Unknown | Charite University, Berlin, Germany | 132 | 2022-03-04 | 2022-03-24 |
| WILL lOWer Dose Aspirin be Better With Rivaroxaban in Patients With Chronic Coronary Syndromes? Aspirin 75mg, Aspirin 20mg, Rivaroxaban 2.5 mg - Coronary Syndrome | Phase 4 | Completed | Sheffield Teaching Hospitals NHS Foundation Trust | 48 | 2021-08-26 | 2026-02-20 |
| Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial). Coronary angiography, OCT imaging, Percutaneous coronary intervention (PCI): - Myocardial Infarction With Non-Obstructive Coronary Arteries | Phase 4 | Unknown | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 120 | 2021-07-01 | 2024-07-26 |
| Efficacy and Safety of Shexiang Baoxin Pill in Patients With Ischemia With Non-Obstructive Coronary Artery Shexiang Baoxin pill（MUSKARDIA）, Placebo - Ischemia With Non-Obstructive Coronary Artery, Angina Pectoris | Phase 4 | Completed | Shanghai Hutchison Pharmaceuticals Limited | 240 | 2021-05-11 | 2024-04-23 |
| Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris Wen Xin granule, Clopidogrel Hydrogen Sulfate 75 MG Oral Tablet, Atorvastatin Calcium - Coronary Heart Disease, Unstable Angina | Phase 4 | Unknown | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 502 | 2021-03-01 | 2021-01-25 |
| Evaluate the Efficacy and Safety of MUSK Pill on Coronary Microvascular Dysfunction MUSK pill - Angina Pectoris, Coronary Heart Disease | Phase 4 | Unknown | Shanghai Hutchison Pharmaceuticals Limited | 264 | 2021-01-28 | 2021-08-02 |
Showing 20 of 166. Sign in to see all of them.
Angina, Unstable (56) · Angina, Stable (52) · Coronary Artery Disease (40) · Myocardial Infarction (22) · Acute Coronary Syndrome (18) · Coronary Disease (18) · Microvascular Angina (16) · Non-ST Elevated Myocardial Infarction (13) · Myocardial Ischemia (10) · ST Elevation Myocardial Infarction (9) · Angina Pectoris, Variant (8) · Cardiovascular Diseases (6) · Coronary Stenosis (6) · Diabetes Mellitus (6)
Vascular Diseases (164) · Heart Diseases (161) · Cardiovascular Diseases (160) · Pathological Conditions, Signs and Symptoms (157) · Myocardial Ischemia (156) · Neurologic Manifestations (155) · Pain (155) · Signs and Symptoms (155) · Chest Pain (150) · Arterial Occlusive Diseases (45) · Pathologic Processes (45) · Arteriosclerosis (43) · Coronary Disease (39) · Necrosis (36)
Atorvastatin (13) · Ticagrelor (13) · Clopidogrel (12) · Ranolazine (11) · Nitroglycerin (9) · Aspirin (8) · Hydroxymethylglutaryl-CoA Reductase Inhibitors (5) · Nicorandil (5) · Percutaneous Coronary Intervention (5) · Prasugrel Hydrochloride (5) · Heparin (4) · Lipid Regulating Agents (4) · Metoprolol (4) · Pravastatin (4) · Rosuvastatin Calcium (4)
Collegium Medicum w Bydgoszczy (4) · Guang'anmen Hospital of China Academy of Chinese Medical Sciences (4) · Jun Li (4) · Qilu Hospital of Shandong University (4) · Seoul National University Hospital (4) · Yonsei University (4) · Azienda Policlinico Umberto I (3) · China Academy of Chinese Medical Sciences (3) · Deutsches Herzzentrum Muenchen (3) · Kobe University (3) · Samsung Medical Center (3) · Seung-Jung Park (3) · Aarhus University Hospital Skejby (2) · Cardiology Research UBC (2) · Foundation of Cardiovascular Research and Education Enschede (2)
South Korea (25) · China (22) · United States (19) · United Kingdom (13) · Germany (12) · Italy (12) · Poland (9) · Canada (8) · Japan (8) · Denmark (7) · Netherlands (6) · Spain (5) · Czechia (4) · Belgium (3) · Brazil (3)
Jun Li, MD (6) · Adnan Kastrati, MD (3) · Jacek Kubica, MD., PhD. (3) · Albert Schomig, MD (2) · Naveed Sattar, MBChB PhD (2) · Stuart M Cobbe, MBChB MD (2) · Xiao-xi Du, Professor (2) · Yong Huo, MD (2) · A'Di Chen, Master (1) · Abdullah M Al-Rubaish, MD (1) · Aleem Khand, MBChB MD (1) · Alf-Aage R. Pettersen, M.D. (1) · Allan Struthers, BSc, MD, FRCP, FRSE, FMedSci (1) · Allen Jeremias, MD (1)
PMID 22536282, PMID 23762142, PMID 27777598, PMID 23737852, PMID 25254054, PMID 31829173, PMID 35641327, PMID 37619976, PMID 37745109, PMID 38598970, PMID 39959922, PMID 11320360, PMID 12595860, PMID 14981009, PMID 15313949, PMID 15367828, PMID 16533938, PMID 16720691, PMID 17060377, PMID 17065671, PMID 17145253, PMID 17261652, PMID 17314342, PMID 17398308, PMID 17467513, PMID 18227366, PMID 18230778, PMID 18427132, PMID 18451347, PMID 18667204, PMID 18703471, PMID 18777490, PMID 18972097, PMID 19151200, PMID 19423946, PMID 19433695, PMID 19447387, PMID 19540640, PMID 19840579, PMID 20075143, PMID 20145342, PMID 20150324, PMID 20220183, PMID 20223369, PMID 20484828, PMID 20494902, PMID 20579539, PMID 20629665, PMID 21146654, PMID 21426546
2008 (1), 2016 (1), 2023 (1), K76AG088428 (1)